On one hand, CCL2 can elicit immunosuppressive effects and support tumor progression by promoting increased invasion through angiogenesis (95), while on the other, it can induce the production of pro-inflammatory cytokines in macrophages to augment their survival (96). The gene discussed is CCL2; the disease is neoplasm.